Trisalus Life SciencesTLSI
13F holders, Q2 2025 (June 30)46holders +12
20new positions
8sold out
1famous investor
$5.45avg. 13F price*
At the end of Q2 2025, 46 institutions reported holding Trisalus Life Sciences Inc. (TLSI) in their 13F filings, up 12 from Q1 2025. 20 opened new positions and 8 sold out. The largest holders were Nantahala Capital Management, LLC ($10.9M), AWM Investment Company, Inc. ($6.8M) and Gilder Gagnon Howe & Co. LLC ($6.0M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Trisalus Life Sciences Inc.
- CUSIP
- 89680M101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 20 | $21.6M |
| Exits | 8 | $586K |
All 13F filers, Q1 2025 → Q2 2025: 5,748,853 shares bought and 226,395 shares sold, net +5,522,458 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 46 holders
| Nantahala Capital Management, LLC | 0.77% | New | 2,000,000 | $10.9M |
| AWM Investment Company, Inc. | 0.76% | New | 1,250,000 | $6.8M |
| Gilder Gagnon Howe & Co. LLC | 0.06% | Add +32.1% | 1,092,975 | $6.0M |
| Vanguard Group Inc. | 0.00% | Add +67.4% | 814,389 | $4.4M |
| Wealthcare Advisory Partners LLC | 0.08% | No change | 643,740 | $3.5M |
| BlackRock, Inc. | 0.00% | Add +1953.8% | 621,689 | $3.4M |
| Alyeska Investment Group, L.P. | 0.01% | New | 557,500 | $3.0M |
| Geode Capital Management, LLC | 0.00% | Add +107.4% | 455,051 | $2.5M |
| Bank of America Corp. | 0.00% | Add +1.8% | 188,906 | $1.0M |
| Northern Trust Corp. | 0.00% | Add +216.2% | 126,263 | $688K |
| State Street Corp. | 0.00% | Add +472.3% | 115,597 | $630K |
| Bridgeway Capital Management, LLC | 0.01% | Add +16.0% | 75,400 | $411K |
| Morgan Stanley | 0.00% | Add +2285.8% | 56,328 | $307K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +400.1% | 50,012 | $273K |
| Bank of New York Mellon Corp | 0.00% | New | 41,801 | $228K |
| MSD Partners, L.P. | 0.13% | No change | 39,999 | $218K |
| Connective Capital Management, LLC | 0.17% | Add +12.8% | 32,796 | $179K |
| Millennium Management | 0.00% | Reduce -77.3% | 30,253 | $165K |
| Barclays PLC | 0.00% | Add +93453.1% | 29,937 | $163K |
| Vestcor Inc | 0.00% | No change | 23,376 | $127K |
| Connecticut Wealth Management, LLC | 0.01% | No change | 22,303 | $122K |
| Nuveen, LLC | 0.00% | New | 20,594 | $112K |
| Susquehanna International Group, LLP | 0.00% | New | 20,558 | $112K |
| New York State Common Retirement Fund | 0.00% | New | 19,800 | $108K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Add +25.1% | 19,454 | $106K |
| Deutsche Bank AG | 0.00% | New | 19,288 | $105K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -50.4% | 16,816 | $92K |
| UBS Group AG | 0.00% | Add +145.2% | 16,692 | $91K |
| Rhumbline Advisers | 0.00% | New | 16,463 | $90K |
| Wells Fargo & Company | 0.00% | Add +976.4% | 10,775 | $59K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | New | 8,705 | $47K |
| JPMorgan Chase & Co. | 0.00% | Add +35804.8% | 7,540 | $41K |
| Citigroup Inc. | 0.00% | Add +466.5% | 5,427 | $30K |
| Police & Firemen's Retirement System of New Jersey | 0.00% | New | 5,400 | $29K |
| Arax Advisory Partners | 0.00% | No change | 4,008 | $22K |
| BNP Paribas Financial Markets | 0.00% | New | 3,015 | $16K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 1,629 | $9K |
| Legal & General Group Plc | 0.00% | New | 1,454 | $8K |
| California State Teachers Retirement System | 0.00% | New | 996 | $5K |
| Royal Bank of Canada | 0.00% | New | 953 | $4K |
| Hoertkorn Richard Charles | 0.00% | No change | 668 | $4K |
| Wolverine Asset Management LLC | 0.00% | New | 626 | $3K |
| Amalgamated Bank | 0.00% | New | 545 | $3K |
| Sterling Capital Management LLC | 0.00% | New | 339 | $2K |
| Signaturefd, LLC | 0.00% | No change | 100 | $545 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 98 | $534 |
"% of holder's portfolio" is TLSI's weight in each manager's 13F, not the share of Trisalus Life Sciences Inc. the manager owns.